Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
higher degrees » higher degree (Expand Search), high degree (Expand Search), highest degree (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
higher degrees » higher degree (Expand Search), high degree (Expand Search), highest degree (Expand Search)
-
1961
-
1962
-
1963
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
1964
-
1965
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
1966
-
1967
-
1968
-
1969
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
1970
-
1971
-
1972
-
1973
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
1974
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
1975
-
1976
-
1977
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
1978
-
1979
-
1980